Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy.
Garber, A. 1; Klein, E. 2; Bruce, S. 3; Sankoh, S. 3; Mohideen, P. 3
[Article] Diabetes, Obesity & Metabolism. 8(2):156-163, March 2006.

(Format: HTML, PDF)